EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:27673 - herbacetin
| Formula | C15H10O7 |
| Net Charge | 0 |
| Average Mass | 302.238 |
| Monoisotopic Mass | 302.04265 |
| SMILES | O=c1c(O)c(-c2ccc(O)cc2)oc2c(O)c(O)cc(O)c12 |
| InChI | InChI=1S/C15H10O7/c16-7-3-1-6(2-4-7)14-13(21)12(20)10-8(17)5-9(18)11(19)15(10)22-14/h1-5,16-19,21H |
| InChIKey | ZDOTZEDNGNPOEW-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Rhodiola rosea (ncbitaxon:203015) | - | PubMed (31356124) | Identified in rhizomes and roots. |
| Ephedra sinica (ncbitaxon:33152) | - | PubMed (24081687) |
| Roles Classification |
|---|
| Biological Roles: | EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor An EC 3.4.22.* (cysteine endopeptidase) inhibitor that interferes with the action of SARS coronavirus main proteinase (EC 3.4.22.69). plant metabolite Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 4.1.1.17 (ornithine decarboxylase) inhibitor An EC 4.1.1.* (carboxy-lyase) inhibitor that interferes with the action of ornithine decarboxylase (EC 4.1.1.17). |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. antilipemic drug A substance used to treat hyperlipidemia (an excess of lipids in the blood). angiogenesis inhibitor An agent and endogenous substances that antagonize or inhibit the development of new blood vessels. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| herbacetin (CHEBI:27673) has functional parent kaempferol (CHEBI:28499) |
| herbacetin (CHEBI:27673) has role angiogenesis inhibitor (CHEBI:48422) |
| herbacetin (CHEBI:27673) has role anti-inflammatory agent (CHEBI:67079) |
| herbacetin (CHEBI:27673) has role antilipemic drug (CHEBI:35679) |
| herbacetin (CHEBI:27673) has role antineoplastic agent (CHEBI:35610) |
| herbacetin (CHEBI:27673) has role apoptosis inducer (CHEBI:68495) |
| herbacetin (CHEBI:27673) has role EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor (CHEBI:147285) |
| herbacetin (CHEBI:27673) has role EC 4.1.1.17 (ornithine decarboxylase) inhibitor (CHEBI:139556) |
| herbacetin (CHEBI:27673) has role plant metabolite (CHEBI:76924) |
| herbacetin (CHEBI:27673) is a 7-hydroxyflavonol (CHEBI:52267) |
| herbacetin (CHEBI:27673) is a pentahydroxyflavone (CHEBI:25883) |
| IUPAC Name |
|---|
| 3,5,7,8-tetrahydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one |
| Synonyms | Source |
|---|---|
| herbacetin | LIPID MAPS |
| 8-hydroxykaempferol | KEGG COMPOUND |
| 3,5,7,8-tetrahydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one | IUPAC |
| 3,4',5,7,8-pentahydroxyflavone | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| C02806 | KEGG COMPOUND |
| CPD-14867 | MetaCyc |
| C00001048 | KNApSAcK |
| LMPK12113149 | LIPID MAPS |
| Herbacetin | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:527-95-7 | ChEBI |
| Citations |
|---|